Active Pharmacovigilance in Peruvian Population: Surveillance of a Timolol/Brimonidine/Dorzolamide Ophthalmic Fixed Combination [Erratum]
Contreras-Salinas H, Barajas-Hernández M, Baiza-Durán LM, Vázquez-Álvarez AO, Bautista-Castro MA, Rodríguez-Herrera LY. Clin Ophthalmol. 2021;15:583-590. On page 587, Table 3 was distorted during the correction stage and published in error. The correct Table 3is shown in Download Article. Table 3 AD...
Gespeichert in:
Veröffentlicht in: | Clinical ophthalmology (Auckland, N.Z.) N.Z.), 2022-02, Vol.16, p.245-246 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Contreras-Salinas H, Barajas-Hernández M, Baiza-Durán LM, Vázquez-Álvarez AO, Bautista-Castro MA, Rodríguez-Herrera LY. Clin Ophthalmol. 2021;15:583-590. On page 587, Table 3 was distorted during the correction stage and published in error. The correct Table 3is shown in Download Article. Table 3 ADRs of TBD vs Reported by Individual Active Ingredient This error was introduced by the typesetting team during the editing process and was not picked up before publication. Read the original article |
---|---|
ISSN: | 1177-5483 1177-5467 1177-5483 |
DOI: | 10.2147/OPTH.S359723 |